Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors
- 31 October 2010
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 49 (10), 1011-1023
- https://doi.org/10.1016/j.jaac.2010.06.015
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Dynamic Network Connectivity: A new form of neuroplasticityTrends in Cognitive Sciences, 2010
- Stress signalling pathways that impair prefrontal cortex structure and functionNature Reviews Neuroscience, 2009
- Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in ratsPsychopharmacology, 2009
- Noradrenergic genotype predicts lapses in sustained attentionNeuropsychologia, 2009
- A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disordersJournal of Neural Transmission, 2008
- Differential Contributions of Dopamine and Serotonin to Orbitofrontal Cortex Function in the MarmosetCerebral Cortex, 2008
- Differential Regulation of Fronto-Executive Function by the Monoamines and AcetylcholineCerebral Cortex, 2007
- Catecholamine and Second Messenger Influences on Prefrontal Cortical Networks of "Representational Knowledge": A Rational Bridge between Genetics and the Symptoms of Mental IllnessCerebral Cortex, 2007
- Delayed-response deficit induced by local injection of the α2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeysBehavioral and Neural Biology, 1994
- Methylphenidate and Cognitive Perseveration in Hyperactive ChildrenJournal of Child Psychology and Psychiatry, 1992